1-12 of 12
Yu Qin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety and Efficacy of a-319 (a CD3xCD19 T cell engager) in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Wei Ping Liu, Bo Jiang, Yue Rong Shuang, Xing Zhao, Xuan Fan Zhong, Ying Tan, Guo Jian Yu, Sheng Jie Xue, Wu Zhong Shen, Gui Yun Tu, Zheng Yang, Han Yang Chen, Jason Xu, Shui Liu, Xiao Qiang Qiang Yan, Jun Zhu, Yu Qin Song
Journal: Blood
Blood (2023) 142 (Supplement 1): 6158.
https://doi.org/10.1182/blood-2023-188071
Published: 2023
Journal Articles

Glofitamab Monotherapy Demonstrates High Complete Response Rates and Manageable Safety in Chinese Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma and ≥2 Prior Therapies

Yu-Qin Song, Hui-Lai Zhang, Hui-Qiang Huang, Qing-Yuan Zhang, Hong-Mei Jing, Chao Wang, Chun Wu, Dong-Hang Li, Yu Dai, Kathryn Humphrey, Jun Zhu
Journal: Blood
Blood (2022) 140 (Supplement 1): 12050–12051.
https://doi.org/10.1182/blood-2022-157544
Published: 2022
Journal Articles

AURKA Regulates the Mechanism of ATR Mediated DNA Damage Response about Drug Resistance in Multiple Myeloma

Zhang Shuaishuai, MD, Yu Qin, An Gang, MD, Mu Hao, PhD, Yan Xu, MD, Shuhui Deng, Tengteng Yu, Wen Zhou, Lugui Qiu, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5354.
https://doi.org/10.1182/blood.V130.Suppl_1.5354.5354
Published: 2017
Journal Articles

Serum High Expression of Micorna-214 Is a Novel Predictor for Myeloma Bone Disease and Poor Prognosis

Mu Hao, MD PhD, Meirong Zang, PhD, Yan Xu, MDPhD, Yu Qin, MD PhD, Lei Zhao, MD PhD, Shuhui Deng, MD PhD, Weiwei Sui, MD, Gang An, MDPhD, Zengjun Li, MD PhD, Yi Shuhua, MD PhD, Fenghuang Zhan, MD PhD, Lugui Qiu, MD PhD
Journal: Blood
Blood (2015) 126 (23): 4186.
https://doi.org/10.1182/blood.V126.23.4186.4186
Published: 2015
Journal Articles

Clonal Evolution Paths Significantly Impact the Outcome of Myeloma

Xiaoqi Qin, MD, Gang An, MDPhD, Lin-ping Hu, MD, Yu Qin, MD PhD, Yan Xu, MDPhD, Xiaoyan Feng, Meirong Zang, Shuhui Deng, MD PhD, Weiwei Sui, MD, Shuhua Yi, MD PhD, Zengjun Li, Sr., Lin-hua Yang, MD, Tao Cheng, MD, Jianxiang Wang, MD, Lugui Qiu, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1784.
https://doi.org/10.1182/blood.V126.23.1784.1784
Published: 2015
Journal Articles

4SCAR19 Chimeric Antigen Receptor-Modified T Cells As a Breakthrough Therapy for Highly Chemotherapy-Resistant Late-Stage B Cell Lymphoma Patients with Bulky Tumor Mass

Lung-Ji Chang, PhD, Lujia Dong, MD, Jun Zhu, MD, Zhitao Ying, MD, Hao-Hsian Kuo, MSc, Yuchen Liu, MSc, Yu-Qin Song, MD, Xiao-Pei Wang, MD, Yong-Qian Jia, MD, Ting Niu, MD PhD, Ting Liu, MDPhD, Ling Pan, MD, Zhuo-Gang Liu, MD, Tong Li, MD, Ying-Chun Li, MD, Kun Yao, MD, Xiaoyan Ke, MD PhD, Hongmei Jing, MD, Fang Bao, MD
Journal: Blood
Blood (2015) 126 (23): 264.
https://doi.org/10.1182/blood.V126.23.264.264
Published: 2015
Journal Articles

Unmeasurable Serum M-Protein Multiple Myeloma Benefit Less from Bortezomib Than Measurable Myeloma

Xiaoqi Qin, Gang An, MD PhD, Yan Xu, MD PhD, Yu Qin, PhD, Xiaoyan Feng, MD, Meirong Zang, PhD, Weiwei Sui, MD, Shuhui Deng, MD, Shuhua Yi, Wen Zhou, PhD, Lugui Qiu, MD
Journal: Blood
Blood (2014) 124 (21): 2062.
https://doi.org/10.1182/blood.V124.21.2062.2062
Published: 2014
Journal Articles

Hypermethylation of TAp73 Suppresses ABL1-Involved DNA Damage Response in Multiple Myeloma

Mu Hao, PhD, Yu Qin, PhD, Meirong Zang, PhD, Yan Xu, MD PhD, Gang An, MD PhD, Changhong Li, MD, Ye Yang, PhD, Zhimin Gu, PhD, Fenghuang Zhan, MD PhD, Lugui Qiu, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3374.
https://doi.org/10.1182/blood.V124.21.3374.3374
Published: 2014
Journal Articles

Clonal Heterogeneityand Evolutional Paths in Multiple Myeloma Revealed By QM-FISH in Single Cell of Sequential Analysis

Xiaoqi Qin, Gang An, MD PhD, Yu Qin, PhD, Yan Xu, MD PhD, Xiaoyan Feng, MD, Meirong Zang, PhD, Weiwei Sui, MD, Shuhui Deng, MD, Shuhua Yi, Wen Zhou, PhD, Lugui Qiu, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3395.
https://doi.org/10.1182/blood.V124.21.3395.3395
Published: 2014
Journal Articles

MiR-137 Contributes to Drug Susceptibility and Chromosomal Instability of Multiple Myeloma through Targeting AURKA

Yu Qin, PhD, Fei Li, MD, Xiaoqi Qin, Gang An, MD PhD, Mu Hao, PhD, Meirong Zang, PhD, Yan Xu, MD PhD, Wen Zhou, PhD, Hong Chang, Lugui Qiu, MD
Journal: Blood
Blood (2014) 124 (21): 5715.
https://doi.org/10.1182/blood.V124.21.5715.5715
Published: 2014
Journal Articles

Epigenetic Silencing Of Mir-137 Contributes To The Proliferation Of Multiple Myeloma By Targeting AURKA

Yu Qin, Fei Li, Gang An, Mu Hao, PhD., Meirong Zang, Lugui Qiu, MD
Journal: Blood
Blood (2013) 122 (21): 3144.
https://doi.org/10.1182/blood.V122.21.3144.3144
Published: 2013
Journal Articles

The Coexpression of AML1-ETO9a Isoform and AML1-ETO in Acute Myeloid Leukemia M 2 Subtype and Its Clinical Significance.

Hong Zhang, MD, Zi-xing Chen, M.D., Jun He, M.S., Yu-qin Miao, M.D., Jian-nong Cen, Ph.D, Qiao-chen Qiu, M.S
Journal: Blood
Blood (2007) 110 (11): 2390.
https://doi.org/10.1182/blood.V110.11.2390.2390
Published: 2007